Clene Inc. Conversion of Stock, Shares Converted
Clene Inc. (CLNN) reported Conversion of Stock, Shares Converted of 482.70 thousand shares for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-11.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:ConversionOfStockSharesConverted1 · last filed 2022-03-11
- Clene Inc. conversion of stock, shares converted for the quarter ending 2021-12-31 was 0.00 shares.
- Clene Inc. conversion of stock, shares converted for the quarter ending 2021-09-30 was 0.00 shares.
- Clene Inc. conversion of stock, shares converted for the quarter ending 2021-06-30 was -1.92M shares.
- Clene Inc. conversion of stock, shares converted for the quarter ending 2021-03-31 was 2.41M shares.
- Clene Inc. conversion of stock, shares converted for fiscal 2021 was 482.70K shares, a 98.69% decline from fiscal 2020.
- Clene Inc. conversion of stock, shares converted for fiscal 2020 was 36.89M shares.
| Period end | Conversion of Stock, Shares Converted 3 month | Conversion of Stock, Shares Converted 6 month | Conversion of Stock, Shares Converted 9 month | Conversion of Stock, Shares Converted 12 month |
|---|---|---|---|---|
| 2021-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | 0.00 shares derived: sum of 2 quarters · filed 2022-03-11 | -1.92M shares derived: sum of 3 quarters · filed 2022-03-11 | 482.70K shares 10-K · filed 2022-03-11 |
| 2021-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | -1.92M shares derived: sum of 2 quarters · filed 2021-11-08 | 482.70K shares 10-Q · filed 2021-11-08 | |
| 2021-06-30 | -1.92M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | 482.70K shares 10-Q · filed 2021-08-09 | ||
| 2021-03-31 | 2.41M shares 10-Q · filed 2021-05-10 | |||
| 2020-12-31 | 36.89M shares 10-K · filed 2021-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B |